Electroconvulsive therapy

Current Opinion in Anaesthesiology

Volumn 10, Issue 4, 1997, Pages 297-302

  Berendes, Elmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ESMOLOL; FENTANYL; LABETALOL; MIVACURIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PROLACTIN; PROPOFOL; SUXAMETHONIUM; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROLACTIN RELEASE; REVIEW; SAFETY; SCHIZOPHRENIA; SEIZURE;

EID: 0030789449     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199708000-00012     Document Type: Review

References (80)

1. Selvin BL: Electroconvulsive therapy - 1987. Anesthesiology 1987, 67:367-385.
2. Rice EH, Sombrotto LS, Markowitz JC, Leon AC: Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry 1994, 151:1637-1641.
3. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA: Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993, 150:904-909.
4. Goetz KL, Price TRP: Electroconvulsive therapy in Creutzfeldt-Jakob disease [Case report]. Convuls Ther 1993, 9:58-62.
5. Potter WZ, Rudorfer MV: Electroconvulsive therapy - a modern medical procedure [Editorial]. N Engl J Med 1993, 328:883-883.
6. Fink M: The next challenge: the mode of action of ECT [Annotation]. Convuls Ther 1993, 9:192-197.
7. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM: Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993, 328:839-846.
8. Swartz CM: Anesthesia for ECT. Convuls Ther 1993, 9:301-316.
9. Fink M: Prolonged seizures [Editorial]. Convuls Ther 1993, 9:87-89.
10. Sackeim HA, Long J, Luber B, Moeller JR, Prohovnik I, Devanand DP, Nobler MS: Physical properties of the ECT stimulus: I. Basic principles. Convuls Ther 1994, 10:93-123.
11. Rasmussen KG, Zorumski CF, Jarvis MR: Possible impact of stimulus duration on seizure threshold in ECT. Convuls Ther 1994, 10:177-180.
12. McCall WV, Reid S, Ford M: Electrocardiographic and cardiovascular effects of subconvulsive stimulation during titrated right unilateral ECT. Convuls Ther 1994, 10:25-33.
13. Abrahms R: Stimulus parameters and efficacy of ECT [Commentary]. Convuls Ther 1994, 10:124-128.
14. Swartz CM: Beyond seizure duration as a measure of treatment quality [Editorial]. Convuls Ther 1993, 9:1-7.
15. Barry S, Rowan MJ, Mulhall J, Webb MGT: Change in barbiturate anaesthetic sensitivity as a prognostic indicator of electroconvulsive therapy outcome. Acta Psychiatr Scand 1991, 83:251-255.
16. Malsch E, Gratz I, Mani S, Backup C, Levy S, Allen E: Efficacy of electroconvulsive therapy after propofol and methohexital anesthesia. Convuls Ther 1994, 10:212-219.
17. Karliner W: Special lecture presented at the 1994 annual meeting of the ACT. Maintenance ECT. Convuls Ther 1994, 10:238-243.
18. Fink M, Abrahms R, Bailine S, Jaffe R: Ambulatory electroconvulsive therapy: report of a task force of the Association for Convulsive Therapy. Convuls Ther 1996, 12:42-55.
19. Fink M, Kellner CH: A second quiet revolution: ambulatory ECT. Convuls Ther 1996, 12:1-2.
20. Engelhardt W, Carl G, Hartung E: Intra-individual open comparison of burst-suppression-isoflurane-anaesthesia versus electroconvulsive therapy in the treatment of severe depression. Eur J Anaesthesiol 1993, 10:113-118.
21. Sackeim HA: Magnetic stimulation therapy and ECT [Commentary]. Convuls Ther 1994, 10:225-258.
22. George MS, Wassermann EM: Rapid-rate transcranial magnetic stimulation and ECT [Editorial]. Convuls Ther 1994, 10:251-254.
23. Fink M: Post-ECT delirium. Convuls Ther 1993, 9:326-330.
24. Folkerts H: Migraine after electroconvulsive therapy. Convuls Ther 1995, 11:212-215.
25. O'Flaherty D, Giesecke AH: Electroconvulsive therapy and anesthesia. Curr Opin Anaesthesiol 1991, 4:436-440.
26. McCall WV: Antihypertensive medications and ECT. Convuls Ther 1993, 9:317-325.
27. Zervas IM, Calev A, Jandorf L, Fink M: Blood pressure, memory, and electroconvulsive therapy. Convuls Ther 1993, 9:14-22.
28. Weinger MB, Partridge BL, Hauger R, Mirow A, Brown M: Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and Cortisol. Anesth Analg 1991, 73:563-569.
29. Zis AP, McGarvey KA, Clark CM, Lam RW, Patrick L, Adams SA: Effect of stimulus energy on electroconvulsive therapy-induced prolactin release. Convuls Ther 1993, 9:23-27.
30. McCall WV , Weiner RD, Carroll BJ, Shelp FE, Ritchie JC, Austin S, Norris J: Serum prolactin, electrode placement, and the convulsive threshold during ECT. Convuls Ther 1996, 12:81-85.
31. Francis A, Fochtmann L: Sustained downregulation of cortical adrenergic receptor density with maintenance electroconvulsive stimulation. Convuls Ther 1993, 9:185-191.
32. Reddy S, Nobler MS: Dangerous hyperglycemia associated with electroconvulsive therapy [Case report]. Convuls Ther 1996, 12:99-103.
33. McCall WV: Asystole in electroconvulsive therapy: report of four cases. J Clin Psychiatry 1996, 57:199-203.
34. Weinger MB, Partridge BL, Hauger R, Mirow A: Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. effectiveness of pretreatment regimens on hemodynamics. Anesth Analg 1991, 73:556-562.
35. Dec GW, Stern TA, Welch C: The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. JAMA 1985, 253:2525-2529.
36. Kaufmann KR: Asystole with electroconvulsive therapy. J Intern Med 1994, 235:275-277.
37. O'Connor CJ, Rothenberg DM, Soble JS, Macioch JE, McCarthy R, Neumann A, Tuman KJ: The effect of esmolol pretreatment on the incidence of regional wall motion abnormalities during electroconvulsive therapy. Anesth Analg 1996, 82:143-147. An interesting study revealing that new regional wall motion abnormalities during ECT are uncommon.
38. Messina AG, Paranicas M, Katz B, Markowitz J, Yao Fun-Sun, Devereux RB: Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. Anesth Analg 1992, 75:511-514.
39. Zhu WX, Olson DE, Karon BL, Tajik AJ: Myocardial stunning after electroconvulsive therapy [Case report]. Ann Int Med 1992, 117:914-915.
40. Castelli I, Steiner LA, Kaufmann MA, Alfillé PH, Schouten R, Welch CA, Drop LJ: Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg 1995, 80:557-561.
41. Dowling FG, Francis A: Aortic aneurysm and electroconvulsive therapy [Case report]. Convuls Ther 1993, 9:121-127.
42. Petrides G, Fink M: Atrial fibrillation, anticoagulation, and electroconvulsive therapy [Case report]. Convuls Ther 1996, 12:91-98.
43. Räsänen J, Martin DJ, Downs JB, Hodges MR: Oxygen supplementation during electroconvulsive therapy. Br J Anaesth 1988, 61:593-597.
44. Chater SN, Simpson KH: Effect of passive hyperventilation on seizure duration in patients undergoing electroconvulsive therapy. Br J Anaesth 1988, 60:70-73.
45. McCormick ASM, Saunders DA: Oxygen saturation of patients recovering from electroconvulsive therapy. Anaesthesia 1996, 51:702-704.
46. Potter WZ, Rudorfer MV, Manji H: The pharmacologic treatment of depression. N Engl J Med 1991, 325:633-634.
47. Pritchett JT, Bernstein HJ, Kellner CH: Combined ECT and antidepressant drug therapy. Convuls Ther 1993, 9:256-261.
48. Murkherjee S: Combined ECT and lithium therapy. Convuls Ther 1993, 9:274-284.
49. Stern RA, Steketee MC, Durr AL, Prange AJ, Golden RN: Combined use of thyroid hormone and ECT. Convuls Ther 1993, 9:285-292.
50. Klapheke MM: Combining ECT and antipsychotic agents: benefits and risks. Convuls Ther 1993, 9:241-255.
51. Fink M: ECT and drugs [Editorial]. Convuls Ther 1993, 9:237-240.
52. Nobler MS, Sackeim HA: Augmentation strategies in electroconvulsive therapy: a synthesis. Convuls Ther 1993, 9:331-351.
53. Kramer BA, Afrasiabi A, Pollock VE: Intravenous versus intramuscular atropine in ECT. Am J Psychiatry 1992, 149:1258-1260.
54. Kramer BA: Anticholinergics and ECT. Convuls Ther 1993, 9:293-300.
55. O'Flaherty D, Husain MM, Moore M, Wolff TR, Sills S, Giesecke AH: Circulatory responses during electroconvulsive therapy. Anaesthesia 1992, 47:563-567.
56. Howie MB, Black HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA: Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg 1990, 71:384-388.
57. Kovac AL, Goto H, Pardo MP, Arkawa K: Comparison of two esmolol bolus doses on the hemodynamic response and seizure duration during electroconvulsive therapy. Can J Anaesth 1991, 38:204-209.
58. Simpson KH, Halsall PJ, Carr CME, Stewart KG: Propofol reduces seizure duration in patients having anaesthesia for electroconvulsive therapy. Br J Anaesth 1988, 61:343-344.
59. Dwyer R, McCaughey W, Lavery J, McCarthy G, Dundee JW: Comparison of propofol and methohexitone as anaesthetic agents for electroconvulsive therapy. Anaesthesia 1988, 43:459-462.
60. Fredmann B, Husain MM, White P: Anaesthesia for electroconvulsive therapy: use of propofol revisited. Eur J Anaesthiol 1994, 11:423-425.
61. Avramov MN, Husain MM, White P: The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995, 81:596-602.
62. Fear CF, Littlejohns CS, Rouse E, McQuail P: Propofol anaesthesia in electroconvulsive therapy. Br J Psychiatry 1994, 165:506-509.
63. Mårtensson B, Bartfari A, Hallén B, Hellström C, Junthé T, Olander M: A comparison of propofol and methohexital as anesthestic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry 1994, 35:173-178.
64. Matters RM, Beckett WG, Kirkby KC, King TE: Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. Br J Anaesth 1995, 75:297-300.
65. Fredman B, d'Etienne J, Smith I, Husain M, White P: Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesth Analg 1994, 79:75-79.
66. Rampton AJ, Griffin RM, Stuart CS, Durcan JJ, Huddy NC, Abbott MA: Comparison of methohexital and propofol for electroconvulsive therapy: effects on hemodynamic responses and seizure duration. Anesthesiohgy 1989, 70:412-417.
67. Rouse EC: Propofol for electroconvulsive therapy. A comparison with methohexitone. Anaesthesia 1988, 43:61-64.
68. Boey WK, Lai FO: Comparison of propofol and thiopentone as anaesthetic agents for electroconvulsive therapy. Anaesthesia 1990, 45:623-628.
69. Villalonga A, Bernado M, Gomar C, Fita G, Esconar R, Pachecho M: Cardiovascular response and anesthetic recovery in electroconvulsive therapy with propofol or thiopental. Convuls Ther 1993, 9:108-111.
70. Mitchell P, Smythe G, Torda T: Effect of the anesthetic agent propofol on hormonal responses to ECT. Biol Psychiatry 1990, 28:315-324.
71. Loimer N, Hofmann P, Chaudhry HR: Midazolam shortens seizure duration following electroconvulsive therapy. J Psychiatry Res 1992, 26:97-101.
72. Trzepacz PT, Weniger FC, Greenhouse J: Etomidate anesthesia increases seizure duration during ECT. A retrospective study. Gen Hosp Psychiatry 1993, 15:115-120.
73. Ilivicky H, Caroff SN, Simone AF: Etomidate during ECT for elderly seizure-resistant patients [Letter]. Am J Psychiatry 1995, 152:957-958.
74. Mokrinski BK, Nagle SE, Papuchis GC, Cohen SM, Waxman GJ: Electroconvulsive therapy-induced cardiac arrhythmias during anesthsia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth 1992, 4:208-212.
75. Greenberg RM, Pettinati HM: Benzodiazepines and electroconvulsive therapy. Convuls Ther 1993, 9:262-273.
76. Dinwiddie SH, Isenberg KE: Combined alfentanil - methohexital anesthesia in electroconvulsive therapy. Convuls Ther 1995, 11:170-176.
77. Burnstein RM, Denny N: Mivacurium in electroconvulsive therapy [Letter]. Anaesthesia 1993, 18:1116.
78. Fredman B, Smith I, d'Etienne J, White P: Use of muscle relaxants for electroconvulsive therapy: how much is enough? [Letter]. Anesth Analg 1994, 78:190-191.
79. Kelly D, Brull SJ: Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinychloline? Can J Anaesth 1994, 41:845-849.
80. Janis K, Hess J, Fabian JA, Gillis M: Substitution of mivacurium for succinylcholine for ECT in eldery patients. Can J Anaesth 1995, 42:612-613.